Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus

Design and development of an effective drug to combat the 2019 novel coronavirus remains a challenge. Therefore, it is of interest to study the binding features of 1615 FDA approved drugs with the recently known 2019-nCoV main protease structure having high sequence homology with that from SARS-CoV....

Descripción completa

Detalles Bibliográficos
Autores principales: Odhar, Hasanain Abdulhameed, Ahjel, Salam Waheed, Albeer, Ali A.Mohammed Ali, Hashim, Ahmed Fadhil, Rayshan, Ali Mahmood, Humadi, Suhad Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147498/
https://www.ncbi.nlm.nih.gov/pubmed/32308266
http://dx.doi.org/10.6026/97320630016236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147498/
https://www.ncbi.nlm.nih.gov/pubmed/32308266
http://dx.doi.org/10.6026/97320630016236

Ejemplares similares